• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

钙拮抗剂药物对老年重症肌无力的影响。

Influence of calcium antagonist drugs in myasthenia gravis in the elderly.

作者信息

Pina Latorre M A, Cobeta J C, Rodilla F, Navarro N, Zabala S

机构信息

Service of Neurology, Hospital Obispo Polanco, Teruel, Spain.

出版信息

J Clin Pharm Ther. 1998 Oct;23(5):399-401. doi: 10.1046/j.1365-2710.1998.00172.x.

DOI:10.1046/j.1365-2710.1998.00172.x
PMID:9875690
Abstract

A number of drugs have been reported to cause neuromuscular blockade and/or to increase weakness in myasthenia gravis. We report on two patients, treated with felodipine and nifedipine for arterial hypertension, who presented with an exacerbation of their myasthenia gravis and a myasthenic syndrome or exacerbation of myasthenia gravis, respectively. The mechanism of action of calcium antagonist drugs at the neuromuscular junction is not yet well established, but it could be located at both presynaptic and postsynaptic levels.

摘要

据报道,一些药物可导致神经肌肉阻滞和/或加重重症肌无力患者的肌无力症状。我们报告了两名因动脉高血压接受非洛地平和硝苯地平治疗的患者,他们分别出现了重症肌无力加重和肌无力综合征或重症肌无力病情加重的情况。钙拮抗剂药物在神经肌肉接头处的作用机制尚未完全明确,但可能存在于突触前和突触后水平。

相似文献

1
Influence of calcium antagonist drugs in myasthenia gravis in the elderly.钙拮抗剂药物对老年重症肌无力的影响。
J Clin Pharm Ther. 1998 Oct;23(5):399-401. doi: 10.1046/j.1365-2710.1998.00172.x.
2
Drug related crisis in myasthenia gravis.重症肌无力的药物相关危机
J Assoc Physicians India. 2006 Oct;54:820-1.
3
Clinical outcome of a mandatory formulary switch for dihydropyridine calcium channel blocker therapy at a Veteran's Administration Medical Center.一家退伍军人管理局医疗中心强制更换二氢吡啶类钙通道阻滞剂治疗方案的临床结果。
Am J Hypertens. 1996 Apr;9(4 Pt 1):312-6. doi: 10.1016/0895-7061(95)00358-4.
4
Comparative trial of felodipine and nifedipine in refractory hypertension.非洛地平与硝苯地平治疗顽固性高血压的对比试验。
Drugs. 1985;29 Suppl 2:117-23. doi: 10.2165/00003495-198500292-00021.
5
Efficacy and safety of a therapeutic interchange from high-dose calcium channel blockers to a fixed-dose combination of amlodipine/benazepril in patients with moderate-to-severe hypertension.中重度高血压患者从高剂量钙通道阻滞剂治疗转换为氨氯地平/贝那普利固定剂量联合治疗的疗效与安全性
J Hum Hypertens. 2001 Aug;15(8):559-65. doi: 10.1038/sj.jhh.1001230.
6
Overview of the safety of felodipine based on clinical trials in patients with hypertension.
Am J Cardiol. 1997 Apr 1;79(7):996-9. doi: 10.1016/s0002-9149(97)00034-9.
7
A comparison of the antihypertensive efficacy and safety of felodipine IV and nifedipine IV in patients with hypertensive crisis or emergency not responding to oral nifedipine.
Eur J Clin Pharmacol. 1998 Jun;54(4):295-8. doi: 10.1007/s002280050462.
8
A randomised trial to compare the efficacy and safety of Felodipine (Plendil) and Nifedipine (Adalat) retard in patients with mild-to-moderate hypertension.一项比较非洛地平(波依定)和硝苯地平缓释片(拜新同)治疗轻至中度高血压患者疗效及安全性的随机试验。
West Afr J Med. 2001 Oct-Dec;20(4):196-202.
9
Dihydropyridines are not substitutable without careful monitoring.二氢吡啶类药物若无仔细监测不可替代。
S Afr Med J. 2002 Aug;92(8):596.
10
Differential effects of felodipine and nifedipine on 24-h blood pressure and left ventricular mass.非洛地平和硝苯地平对24小时血压及左心室质量的不同影响。
Am J Hypertens. 1995 Jul;8(7):712-8. doi: 10.1016/0895-7061(95)00117-8.

引用本文的文献

1
Effect of the Administration of Cautionary Drugs on the Risk of Worsening Myasthenia Gravis: A Retrospective Matched Case-Control Study.使用警示药物对重症肌无力病情恶化风险的影响:一项回顾性配对病例对照研究。
Yonsei Med J. 2025 Apr;66(4):218-225. doi: 10.3349/ymj.2024.0017.
2
Pyridostigmine-induced coronary artery spasm in early-onset myasthenia gravis: a case presentation and review of the literature.吡斯的明诱发早发型重症肌无力患者冠状动脉痉挛:病例报告及文献复习。
BMJ Case Rep. 2022 Sep 14;15(9):e249819. doi: 10.1136/bcr-2022-249819.
3
Drugs That Induce or Cause Deterioration of Myasthenia Gravis: An Update.
诱发或导致重症肌无力病情恶化的药物:最新进展
J Clin Med. 2021 Apr 6;10(7):1537. doi: 10.3390/jcm10071537.
4
Myasthenic crisis.重症肌无力危象
Neurohospitalist. 2011 Jan;1(1):16-22. doi: 10.1177/1941875210382918.
5
Verapamil-associated cardiogenic shock in a 71-year-old man with myasthenia gravis: a case report.一名71岁重症肌无力男性患者出现维拉帕米相关的心源性休克:病例报告
J Med Case Rep. 2009 Jun 16;3:8219. doi: 10.4076/1752-1947-3-8219.